Validation of albumin platelet product as a non-invasive fibrosis staging tool in patients with chronic HCV-related liver disease
Abstract Background and aim: The Albumin Platelet Product (APP) has emerged as a promising non-invasive biomarker for fibrosis staging in chronic liver disease (CLD). This cross-sectional study aims to evaluate the effectiveness of APP compared to established non-invasive markers of fibrosis in an E...
Saved in:
| Main Authors: | Maha Elsabaawy, Mohamed Eissa, Ahmed Shaban, Madiha Naguib |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-07456-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mean Platelet Volume as a Non-Invasive Marker of Liver Fibrosis in Patients with Chronic Hepatitis B: A Multicenter Study from Rawalpindi and Quetta
by: Muhammad Ishfaq Ahmad, et al.
Published: (2025-04-01) -
Fusion protein of retinol‐binding protein and albumin domain III reduces liver fibrosis
by: Hongsik Lee, et al.
Published: (2015-04-01) -
Assessment of liver fibrosis stage influence on clinical course of periodontal diseases in patients with chronic hepatitis C
by: О. М. Slaba, et al.
Published: (2017-08-01) -
Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2015-05-01) -
Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in Lubumbashi, democratic republic of Congo
by: Arsène Kabamba-Tshikongo, et al.
Published: (2025-02-01)